NIPH Clinical Trials Search

Basic Information

Recruitment status
Health condition(s) or Problem(s) studied	Patients with Type 2 Diabetes
Date of first enrollment	11/05/2010
Target sample size
Countries of recruitment
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : CS-1036 INN of investigational material : Therapeutic category code : 396 Antidiabetic agents Dosage and Administration for Investigational material : Oral

Outcome(s)

Primary Outcome	Postprandial glucose
Secondary Outcome	1. plasma glucose, serum insulin, glycoalbumin, 1,5-anhydroglucitol, HbA1c, and urinary C-peptide 2. Safety and tolerability

Key inclusion & exclusion criteria

Age minimum	>= 20age old
Age maximum	<= 70age old
Gender	Both
Include criteria	Patients diagnosed with type 2 diabetes mellitus
Exclude criteria	- Patient with type 1 diabetes mellitus - Patient with clinically significant diabetic complications